Tamoxifen induces hepatotoxicity and changes to hepatocyte morphology at the early stage of endocrinotherapy in mice.

作者: FANG-FANG GAO , JIA-WEI LV , YING WANG , RONG FAN , QUN LI

DOI: 10.3892/BR.2015.536

关键词:

摘要: Clinically, hepatotoxicity is an inevitable side effect during long-term endocrinotherapy in breast cancer patients. Various studies have reported the specific mechanism and protective methods for this hepatotoxicity, however, short-term influences of tamoxifen (TAM) on hepatocytes remain to be elucidated. The previous study investigated TAM-induced liver injury at early stage endocrine treatment. Mice were assigned into 2 groups: experiment group was administrated with intraperitoneal (i.p.) injection 6 mg/kg/day TAM weeks, control i.p. physiological saline same dose. Body weights each detected every day, alanine aminotransferase aspartate levels measured 3 days. Small pieces tissues obtained processed protein extraction, biochemical detection histopathological analysis weeks later. results indicated that decreased mice body weights. Morphologically, treatment only microscopic ultrastructural structure hepatic cords became blurred sections regions, although lobules remained visible. Partially, cells swelled spherical shapes. Nuclei appeared pyknotic exhibited uneven chromatin distribution. In addition, it observed transmission electron microscopy nuclei unevenly distributed. majority endowed distinct heterochromatin thick nucleoli. mitochondrial cristae vague disorganized. Finally, western blotting used a significant increase caspase-3 level tissues. conclusion, experiments elucidated (6 mg/kg/day) would cause mice, underlying involved hepatocyte apoptosis.

参考文章(30)
E. A. Martin, F. De Matteis, P. Carthew, L. L. Smith, I. N. H. White, B. M. Dorman, R. E. Edwards, R. T. Heydon, Tamoxifen Induces Short-Term Cumulative DNA Damage and Liver Tumors in Rats: Promotion by Phenobarbital Cancer Research. ,vol. 55, pp. 544- 547 ,(1995)
Ghada M. Suddek, Protective role of thymoquinone against liver damage induced by tamoxifen in female rats Canadian Journal of Physiology and Pharmacology. ,vol. 92, pp. 640- 644 ,(2014) , 10.1139/CJPP-2014-0148
Min-Ho Lee, Ji-Won Kim, Ju-Han Kim, Kyung-Sun Kang, Gu Kong, Mi-Ock Lee, Gene expression profiling of murine hepatic steatosis induced by tamoxifen. Toxicology Letters. ,vol. 199, pp. 416- 424 ,(2010) , 10.1016/J.TOXLET.2010.10.008
Hesham A. El-Beshbishy, Hepatoprotective Effect of Green Tea (Camellia sinensis) Extract against Tamoxifen-induced Liver Injury in Rats Journal of Biochemistry and Molecular Biology. ,vol. 38, pp. 563- 570 ,(2005) , 10.5483/BMBREP.2005.38.5.563
Myrto Raftopoulou, Alan Hall, Cell migration: Rho GTPases lead the way. Developmental Biology. ,vol. 265, pp. 23- 32 ,(2004) , 10.1016/J.YDBIO.2003.06.003
Ian N.H. White, Francesco de Matteis, Adrian Davies, Lewis L. Smith, Christopher Crofton-Sleigh, Stanley Venitt, Alan Hewer, David H. Phillips, Genotoxic potential of tamoxifen and analogues in female Fischer F344/n rats, DBA/2 and C57BL/6 mice and in human MCL-5 cells. Carcinogenesis. ,vol. 13, pp. 2197- 2203 ,(1992) , 10.1093/CARCIN/13.12.2197
Hiltrud Brauch, Reiner Hoppe, Joanna Achinger-Kawecka, Stefan Winter, Peter Fritz, Wing-Yee Lo, Werner Schroth, Increased expression of miR-126 and miR-10a predict prolonged relapse-free time of primary oestrogen receptor-positive breast cancer following tamoxifen treatment European Journal of Cancer. ,vol. 49, pp. 3598- 3608 ,(2013) , 10.1016/J.EJCA.2013.07.145
Y Murata, Y Ogawa, T Saibara, A Nishioka, Y Fujiwara, M Fukumoto, T Inomata, H Enzan, S Onishi, S Yoshida, Unrecognized hepatic steatosis and non-alcoholic steatohepatitis in adjuvant tamoxifen for breast cancer patients. Oncology Reports. ,vol. 7, pp. 1299- 1304 ,(2000) , 10.3892/OR.7.6.1299
Derek Weycker, John Edelsberg, Alex Kartashov, Rich Barron, Gary Lyman, Risk and Healthcare Costs of Chemotherapy-Induced Neutropenic Complications in Women with Metastatic Breast Cancer Chemotherapy. ,vol. 58, pp. 8- 18 ,(2012) , 10.1159/000335604